Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Plasmacytoid dendritic cells (pDCs) sense viral and microbial DNA through endosomal Toll-like receptors to produce type 1 interferons. pDCs do not normally respond to self-DNA, but this restriction seems to break down in human autoimmune disease by an as yet poorly understood mechanism. Here we identify the antimicrobial peptide LL37 (also known as CAMP) as the key factor that mediates pDC activation in psoriasis, a common autoimmune disease of the skin. LL37 converts inert self-DNA into a potent trigger of interferon production by binding the DNA to form aggregated and condensed structures that are delivered to and retained within early endocytic compartments in pDCs to trigger Toll-like receptor 9. Thus, our data uncover a fundamental role of an endogenous antimicrobial peptide in breaking innate tolerance to self-DNA and suggest that this pathway may drive autoimmunity in psoriasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the anti-microbial peptide LL37 has been shown to promote trafficking of aggregated DNA structures to the early endosome, promoting TLR9 activation and interferon production (Lande et al., 2007)”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Lande et al., 2007
In the citing paper
“Interestingly, suction blister wounds, where the blister roof is still intact, do not show substantial inflammation,9 whereas excisional wounds, ultraviolet (UV)-induced skin damage, superficial tape stripping or chemical skin irritants, and contact sensitizers cause inflammatory infiltrates,17,23–26”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [23]
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Self-citationEndogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Pathogenesis and therapy of psoriasis
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778
Plasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
Self-citation
Cited by
Items 101–200 of 1,000
Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin
Jiang, Y., Tsoi, L. C., Billi, A. C., Ward, N. L., Harms, P. W., Zeng, C., Maverakis, E., Kahlenberg, J. M., & Gudjonsson, J. E. (2020) · JCI Insight · doi:10.1172/jci.insight.142067 · Cited by 348
The Multitasking Organ: Recent Insights into Skin Immune Function
Di Meglio, P., Perera, G. K., & Nestle, F. O. (2011) · Immunity · doi:10.1016/j.immuni.2011.12.003 · Cited by 348
Self-citationThe Immunology of Psoriasis-Current Concepts in Pathogenesis
Sieminska, I., Pieniawska, M., & Grzywa, T. M. (2024) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-024-08991-7 · Cited by 346
“Complexes consisting of DNA or RNA and LL37 are abundant in lesional skin [19, 106].”
BackgroundSisirak, V., Faget, J., Gobert, M., Goutagny, N., Vey, N., Treilleux, I., Renaudineau, S., Poyet, G., Labidi-Galy, S. I., Goddard-Leon, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3468 · Cited by 345
Neutrophils in the pathogenesis and manifestations of SLE
Kaplan, M. J. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.132 · Cited by 343
“In conjunction with self-DNA release through NETosis, LL-37 also promotes activation of pDC, increasing their expression of co-stimulatory molecules and production of type I IFNs”
BackgroundPhotoimmunology: how ultraviolet radiation affects the immune system
Bernard, J. J., Gallo, R. L., & Krutmann, J. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0185-9 · Cited by 329
Interleukin 17A: Toward a new understanding of psoriasis pathogenesis
Lynde, C. W., Poulin, Y., Vender, R., Bourcier, M., & Khalil, S. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.12.036 · Cited by 335
The Immunopathogenesis of Psoriasis
Kim, J., & Krueger, J. G. (2015) · Dermatologic Clinics · doi:10.1016/j.det.2014.09.002 · Cited by 331
Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis
Guttman-Yassky, E., Lowes, M. A., Fuentes-Duculan, J., Zaba, L. C., Cardinale, I., Nograles, K. E., Khatcherian, A., Novitskaya, I., Carucci, J. A., Bergman, R., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7420 · Cited by 331
“For example, LL37 has recently been shown to be a key activator of DCs in the skin (53) and this could create a “feed forward” or self-amplifying loop between keratinocyte products induced by IL-17 and underlying FIGURE 4.”
BackgroundT Lymphocyte Priming by Neutrophil Extracellular Traps Links Innate and Adaptive Immune Responses
Tillack, K., Breiden, P., Martin, R., & Sospedra, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103414 · Cited by 327
“the pathogenesis of some autoimmune diseases such as psoriasis (19) and systemic lupus erythematosus (22–25), for which it has been suggested that the large amounts of IFN-g produced by NETs-activated pDCs can lead to the maturation of myeloid DCs (mDCs) and exert an effect on T cell function.”
BackgroundAlbanesi, C., Scarponi, C., Pallotta, S., Daniele, R., Bosisio, D., Madonna, S., Fortugno, P., Gonzalvo-Feo, S., Franssen, J.-D., Parmentier, M., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20080129 · Cited by 327
Wang, H., Li, T., Chen, S., Gu, Y., & Ye, S. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39296 · Cited by 325
“NET components, such as DNA coated with antimicrobial peptides (LL37 or human neutrophil peptides), are potent inducers of IFNa production by PDCs (3,25).”
BackgroundNecroptosis in the Pathophysiology of Disease
Khoury, M. K., Gupta, K., Franco, S. R., & Liu, B. (2020) · The American Journal of Pathology · doi:10.1016/j.ajpath.2019.10.012 · Cited by 323
Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation
Toussaint, M., Jackson, D. J., Swieboda, D., Guedán, A., Tsourouktsoglou, T.-D., Ching, Y. M., Radermecker, C., Makrinioti, H., Aniscenko, J., Bartlett, N. W., et al. (2017) · Nature Medicine · doi:10.1038/nm.4332 · Cited by 319
Scanning the Immunopathogenesis of Psoriasis
Chiricozzi, A., Romanelli, P., Volpe, E., Borsellino, G., & Romanelli, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010179 · Cited by 320
“Of note, ma ure DC-LAMP+ mDCs in lesional psoriatic skin co localize with self-RNA-LL37 complexes [57], and pDCs in lesional psoriatic ski co-localize with LL37 [215].”
BackgroundMolecular Dissection of Psoriasis: Integrating Genetics and Biology
Elder, J. T., Bruce, A. T., Gudjonsson, J. E., Johnston, A., Stuart, P. E., Tejasvi, T., Voorhees, J. J., Abecasis, G. R., & Nair, R. P. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.319 · Cited by 320
“Activation of these cells can occur through binding of the antimicrobial peptide LL-37 in complexes with host DNA, with intracellularly expressed TLR9 (Lande et al., 2007).”
Resident and “Inflammatory” Dendritic Cells in Human Skin
Zaba, L. C., Krueger, J. G., & Lowes, M. A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.225 · Cited by 319
“Expression of this antimicrobial peptide is increased during inflammation such as psoriasis, and downstream effects of this increased IFN-α production may be activation of myeloid DCs and initiation of psoriasis (Nestle and Gilliet, 2005).”
BackgroundInfluentialConrad, C., Di Domizio, J., Mylonas, A., Belkhodja, C., Demaria, O., Navarini, A. A., Lapointe, A.-K., French, L. E., Vernez, M., & Gilliet, M. (2018) · Nature Communications · doi:10.1038/s41467-017-02466-4 · Cited by 317
Self-citationAntiviral Mechanisms of Human Defensins
Wilson, S. S., Wiens, M. E., & Smith, J. G. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.09.038 · Cited by 315
“Finally, in line with previous observations about the cathelicidin LL37, HBD2 and HBD3 can bind DNA and promote its uptake by plasmacytoid DCs leading to interferon production [161,162].”
BackgroundResultThe role of IL‐23 and the IL‐23/TH17 immune axis in the pathogenesis and treatment of psoriasis
Girolomoni, G., Strohal, R., Puig, L., Bachelez, H., Barker, J., Boehncke, W. H., & Prinz, J. C. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14433 · Cited by 313
“Complexed with nucleic material, LL-37 has been shown to activate the production of IFN by DCs through ligation of endosomal Toll-like receptors (TLRs).(49,50) Circulating T cells specific to LL-37 were present in 46% of tested patients with psoriasis.”
BackgroundGuttman-Yassky, E., Nograles, K. E., & Krueger, J. G. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.054 · Cited by 314
Di Meglio, P., Villanova, F., & Nestle, F. O. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015354 · Cited by 317
Self-citationRegulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction
Cao, W., Bover, L., Cho, M., Wen, X., Hanabuchi, S., Bao, M., Rosen, D. B., Wang, Y.-H., Shaw, J. L., Du, Q., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090547 · Cited by 313
“It will be of further interest to study if the BST2– ILT7–mediated controlling mechanism is breached in patients with systemic lupus erythematosus and psoriasis (Blanco et al., 2001; Lande et al., 2007; Marshak-Rothstein and Rifkin, 2007), which may provide an opportunity to develop therapeutics to down-modulate pDC a…”
BackgroundInfluentialSelf-citationRegulation of the nucleic acid-sensing Toll-like receptors
Lind, N. A., Rael, V. E., Pestal, K., Liu, B., & Barton, G. M. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00577-0 · Cited by 307
Type I interferon-mediated tumor immunity and its role in immunotherapy
Yu, R., Zhu, B., & Chen, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04219-z · Cited by 309
“Tumor-derived DNA activates the cGAS/STING pathway to drive the expression of type I IFNs through chaperoning HMGB1, autophagosome, exosome, LL37, or CLEC9A into DCs.”
BackgroundInterleukin-17A and Keratinocytes in Psoriasis
Furue, M., Furue, K., Tsuji, G., & Nakahara, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041275 · Cited by 300
“Upon stimulation with complexes of host DNA and LL-37, plasmacytoid dendritic cells produce large amounts of IFN-α [227].”
BackgroundThe DNA Sugar Backbone 2′ Deoxyribose Determines Toll-like Receptor 9 Activation
Haas, T., Metzger, J., Schmitz, F., Heit, A., Müller, T., Latz, E., & Wagner, H. (2008) · Immunity · doi:10.1016/j.immuni.2008.01.013 · Cited by 298
“In fact, similar to PS IRS ODNs, PS 20 deoxyribose homopolymers may manifest therapeutic potential as immunopharmacons for ablation of TLR9 and/or TLR7 activation in certain autoimmune diseases such as lupus erythematosus (Barrat et al., 2005) or psoriasis (Lande et al., 2007).”
BackgroundThe interferon signature in autoimmune diseases
Rönnblom, L., & Eloranta, M.-L. (2013) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32835c7e32 · Cited by 294
“[13] found that the antimicrobial peptide LL37 binds and protects DNA or RNA from degradation, and allowed access of such complexes to early endosomes and triggering of TLR9 and TLR7.”
BackgroundChiang, C.-C., Cheng, W.-J., Korinek, M., Lin, C.-Y., & Hwang, T.-L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02376 · Cited by 289
“Myeloid DCs (mDCs) are then activated to release many proinflammatory mediators, such as IL-6, IL-12, IL-23, and TNFα (91, 92), which play an important role in the initiation of the Th1, Th17, and Th22 cells immune response (16).”
BackgroundSun, J., Furio, L., Mecheri, R., van der Does, A. M., Lundeberg, E., Saveanu, L., Chen, Y., van Endert, P., Agerberth, B., & Diana, J. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.013 · Cited by 292
The Innate Immune System in Acute and Chronic Wounds
MacLeod, A. S., & Mansbridge, J. N. (2016) · Advances in Wound Care · doi:10.1089/wound.2014.0608 · Cited by 289
New Treatment Addressing the Pathogenesis of Psoriasis
Tokuyama, M., & Mabuchi, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207488 · Cited by 291
“Plasmacytoid DCs (pDCs) recognize self-DNA through TLR9 and LL37 is the key factor that mediates pDCs’ activation in psoriasis [15].”
BackgroundAicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity
Crow, Y. J., & Rehwinkel, J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp293 · Cited by 289
Ma, F., Plazyo, O., Billi, A. C., Tsoi, L. C., Xing, X., Wasikowski, R., Gharaee-Kermani, M., Hile, G., Jiang, Y., Harms, P. W., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39020-4 · Cited by 284
Self-citationCytoplasmic DNA: sources, sensing, and role in aging and disease
Miller, K. N., Victorelli, S. G., Salmonowicz, H., Dasgupta, N., Liu, T., Passos, J. F., & Adams, P. D. (2021) · Cell · doi:10.1016/j.cell.2021.09.034 · Cited by 288
The roles of cathelicidin LL-37 in immune defences and novel clinical applications
Nijnik, A., & Hancock, R. E. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32831ac517 · Cited by 287
Miller, L. S. (2008) · Advances in Dermatology · doi:10.1016/j.yadr.2008.09.004 · Cited by 275
“These skin LCs responded to ligands to TLR2, TLR3 and produced IL-6, IL-8, and TNFα, but not IL-12 or IFNα/β (41).”
BackgroundInfluentialCell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases
Duvvuri, B., & Lood, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00502 · Cited by 282
“Consistent with this proposition, cfDNA failed to induce immune responses from plasmacytoid dendritic cells (pDCs), which are otherwise potent responders to microbial nucleic acids (79, 99, 100).”
ResultEarly, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model
Rowland, S. L., Riggs, J. M., Gilfillan, S., Bugatti, M., Vermi, W., Kolbeck, R., Unanue, E. R., Sanjuan, M. A., & Colonna, M. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132620 · Cited by 281
“Dead neutrophils release neutrophil extracellular traps (NETs), which contain endogenous DNA that enters pDC endocytic compartments after forming complexes with cationic proteins (Lande et al., 2007; Tian et al., 2007; Garcia-Romo et al., 2011).”
BackgroundCyclical palmitoylation regulates TLR9 signalling and systemic autoimmunity in mice
Ni, H., Wang, Y., Yao, K., Wang, L., Huang, J., Xiao, Y., Chen, H., Liu, B., Yang, C. Y., & Zhao, J. (2024) · Nature Communications · doi:10.1038/s41467-023-43650-z · Cited by 281
Self-citationOxidative stress in the pathogenesis of psoriasis
Zhou, Q., Mrowietz, U., & Rostami-Yazdi, M. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.033 · Cited by 274
Smith, T. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002469 · Cited by 267
“Cathelicidin hCAP-18/LL37 is also expressed by A549 epithelial cells and, in this context, has been implicated in the pathogenesis of psoriasis (Lande et al., 2007) through a mechanism involving plasmacytoid dendritic cells becoming activated to host DNA.”
BackgroundDendritic Cells In Vivo: A Key Target for a New Vaccine Science
Steinman, R. M. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.001 · Cited by 268
“, 2004) (Lande et al., 2007); the plasmacytoid subset also has special en-”
Herster, F., Bittner, Z., Archer, N. K., Dickhöfer, S., Eisel, D., Eigenbrod, T., Knorpp, T., Schneiderhan-Marra, N., Löffler, M. W., Kalbacher, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13756-4 · Cited by 267
Lai, Y., Li, D., Li, C., Muehleisen, B., Radek, K. A., Park, H. J., Jiang, Z., Li, Z., Lei, H., Quan, Y., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.010 · Cited by 261
“However, in the skin disease psoriasis, the production of IL-17, IL-22, and antimicrobial peptides appears to also contribute to the pathophysiology of the disease (Lande et al., 2007; Zheng et al., 2007).”
BackgroundJiménez-Dalmaroni, M. J., Gerswhin, M. E., & Adamopoulos, I. E. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.08.009 · Cited by 259
“The protein unc-93 homolog B1 (UNC93B1), the cluster of differentiation 14 (CD14) and the cluster of differentiation 36 (CD36), are among the most important accessory molecules of TLRs. UNC93B1 is a multimembrane protein that is essential for the trafficking of endosomal TLRs (TLR3, TLR7, TLR9) from the endoplasmic re…”
InfluentialHuman defensins and LL-37 in mucosal immunity
Doss, M., White, M. R., Tecle, T., & Hartshorn, K. L. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609382 · Cited by 260
“As noted, psoriasis is characterized by markedly increased expression of hBD2 and LL-37, and in this case, LL-37 may contribute to disease pathogenesis by binding to self-DNA, resulting in autoimmune responses directed by DCs [151] .”
BackgroundCathelicidins: Immunomodulatory Antimicrobials
Van Harten, R. M., Van Woudenbergh, E., Van Dijk, A., & Haagsman, H. P. (2018) · Vaccines · doi:10.3390/vaccines6030063 · Cited by 258
“This might actually be a driving factor in autoimmune disease like psoriasis, where LL-37 forms a complex with self-DNA and activates pDCs [91].”
BackgroundSTING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS)
Messaoud-Nacer, Y., Culerier, E., Rose, S., Maillet, I., Rouxel, N., Briault, S., Ryffel, B., Quesniaux, V. F. J., & Togbe, D. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04664-5 · Cited by 256
“Although CpG nucleotides are likely masked by methylation in mammalian self-DNA, cationic antimicrobial peptides such as LL37, human β-defensin (hBD)2, hBD3, or lysozyme condense self-DNA into particles that are endocytosed and trigger TLR9 activation and type I response in pDC and psoriatic skin lesions [21, 22].”
BackgroundCytosolic DNA Sensing in Organismal Tumor Control
Vanpouille-Box, C., Demaria, S., Formenti, S. C., & Galluzzi, L. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.013 · Cited by 250
Chemokine and chemotactic signals in dendritic cell migration
Tiberio, L., Del Prete, A., Schioppa, T., Sozio, F., Bosisio, D., & Sozzani, S. (2018) · Cellular & Molecular Immunology · doi:10.1038/s41423-018-0005-3 · Cited by 256
Antimicrobial peptides important in innate immunity
Cederlund, A., Gudmundsson, G. H., & Agerberth, B. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08302.x · Cited by 256
Behnen, M., Leschczyk, C., Möller, S., Batel, T., Klinger, M., Solbach, W., & Laskay, T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400478 · Cited by 255
“Dysregulation of the release or defects of the clearance of NETs are thought to contribute to autoimmunity and inflammation (29) and have been described for systemic lupus erythematosus (27, 28, 30, 62), small vessel vasculitis (32), MPO/anti-neutrophil cytoplasmic Ab–associated vasculitis (63), lupus nephritis (30),…”
BackgroundFukui, R., Saitoh, S.-I., Matsumoto, F., Kozuka-Hata, H., Oyama, M., Tabeta, K., Beutler, B., & Miyake, K. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082316 · Cited by 254
Host defense peptides and their antimicrobial-immunomodulatory duality
Steinstraesser, L., Kraneburg, U., Jacobsen, F., & Al-Benna, S. (2011) · Immunobiology · doi:10.1016/j.imbio.2010.07.003 · Cited by 247
Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8
Ah Kioon, M. D., Tripodo, C., Fernandez, D., Kirou, K. A., Spiera, R. F., Crow, M. K., Gordon, J. K., & Barrat, F. J. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aam8458 · Cited by 246
Update on psoriasis immunopathogenesis and targeted immunotherapy
Mahil, S. K., Capon, F., & Barker, J. N. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-015-0539-8 · Cited by 245
Self-assembling peptide-based building blocks in medical applications
Acar, H., Srivastava, S., Chung, E. J., Schnorenberg, M. R., Barrett, J. C., LaBelle, J. L., & Tirrell, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.08.006 · Cited by 242
T cells and the skin: from protective immunity to inflammatory skin disorders
Ho, A. W., & Kupper, T. S. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0162-3 · Cited by 241
Antimicrobial peptides in the pathogenesis of psoriasis
MORIZANE, S., & GALLO, R. L. (2012) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2011.01483.x · Cited by 237
Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
Reinholz, M., Ruzicka, T., & Schauber, J. (2012) · Annals of Dermatology · doi:10.5021/ad.2012.24.2.126 · Cited by 236
Skin Barrier Dysregulation in Psoriasis
Orsmond, A., Bereza-Malcolm, L., Lynch, T., March, L., & Xue, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910841 · Cited by 235
Morizane, S., Yamasaki, K., Mühleisen, B., Kotol, P. F., Murakami, M., Aoyama, Y., Iwatsuki, K., Hata, T., & Gallo, R. L. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.259 · Cited by 234
“LL-37 has been reported to form a complex with self-DNA and self-RNA to induce IFN-α in pDCs through TLR9 and TLR7, and hypothesized to drive autoimmunity in psoriasis by this peptide-nucleic acid binding phenomenon (Ganguly et al. , 2009; Lande et al. , 2007).”
The role of neutrophil extracellular traps in rheumatic diseases
Apel, F., Zychlinsky, A., & Kenny, E. F. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0039-z · Cited by 234
Alarmins link neutrophils and dendritic cells
Yang, D., de la Rosa, G., Tewary, P., & Oppenheim, J. J. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.07.004 · Cited by 234
The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis
Schön, M. P., & Erpenbeck, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01323 · Cited by 233
“Interestingly, DNA complexed with LL-37, is much more stable and activates DCs more effectively than “naked” DNA, triggering them to produce pro-inflammatory interferons (98).”
BackgroundTH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26
Meller, S., Di Domizio, J., Voo, K. S., Friedrich, H. C., Chamilos, G., Ganguly, D., Conrad, C., Gregorio, J., Le Roy, D., Roger, T., et al. (2015) · Nature Immunology · doi:10.1038/ni.3211 · Cited by 231
Self-citationPsoriasis: Keratinocytes or Immune Cells – Which Is the Trigger?
Benhadou, F., Mintoff, D., & del Marmol, V. (2019) · Dermatology · doi:10.1159/000495291 · Cited by 227
Tsourouktsoglou, T.-D., Warnatsch, A., Ioannou, M., Hoving, D., Wang, Q., & Papayannopoulos, V. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107602 · Cited by 225
Mast Cells Are Key Mediators of Cathelicidin-Initiated Skin Inflammation in Rosacea
Muto, Y., Wang, Z., Vanderberghe, M., Two, A., Gallo, R. L., & Di Nardo, A. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.222 · Cited by 226
“, 2002) and psoriasis (Lande et al., 2007).”
BackgroundSystemic Lupus Erythematosus Pathogenesis: Interferon and Beyond
Caielli, S., Wan, Z., & Pascual, V. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101921-042422 · Cited by 224
TLR7 and TLR9 in SLE: when sensing self goes wrong
Celhar, T., Magalhães, R., & Fairhurst, A.-M. (2012) · Immunologic Research · doi:10.1007/s12026-012-8270-1 · Cited by 225
“LL37DNA complexes stimulate IFN-a production from pDCs in a TLR9-dependent manner [30], while self-RNA-LL37 complexes activate TLR7-dependent production of IFN-a [189].”
BackgroundInfluentialHänsel, A., Günther, C., Ingwersen, J., Starke, J., Schmitz, M., Bachmann, M., Meurer, M., Rieber, E. P., & Schäkel, K. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.009 · Cited by 223
Role of type I interferons in the activation of autoreactive B cells
Kiefer, K., Oropallo, M. A., Cancro, M. P., & Marshak‐Rothstein, A. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2012.10 · Cited by 223
The origin and properties of extracellular DNA: From PAMP to DAMP
Pisetsky, D. S. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.04.006 · Cited by 222
“LL37, a cathelicidin, is another protein that can bind DNA and enhance its immunostimulatory activity, presumably by facilitating cellular uptake; this activity may be relevant to various diseases such as psoriasis and atherosclerosis where LL37 expression occurs in involved tissues [70,71].”
BackgroundPlasmacytoid dendritic cells: key players in the initiation and regulation of immune responses
Lande, R., & Gilliet, M. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05152.x · Cited by 220
Self-citationCD14 is a coreceptor of Toll-like receptors 7 and 9
Baumann, C. L., Aspalter, I. M., Sharif, O., Pichlmair, A., Blüml, S., Grebien, F., Bruckner, M., Pasierbek, P., Aumayr, K., Planyavsky, M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101111 · Cited by 220
“…studies and allowed for the attribution of further roles to CD14, including clearance of endotoxin (Dunzendorfer et al., 2004), Golgi trafficking of the TLR4 receptor complex (Latz et al., 2002), and the internalization of the TLR2 ligand FSL-1 after signal induction (Shamsul et al., 2010).”
BackgroundLee, H.-M., Shin, D.-M., Yuk, J.-M., Shi, G., Choi, D.-K., Lee, S.-H., Huang, S. M., Kim, J.-M., Kim, C. D., Lee, J.-H., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001954 · Cited by 220
“LL-37 potently activates plasmacytoid dendritic cells to produce type 1 IFNs by binding nonstimulatory self-DNA and causing it to adopt an aggregated and condensed structure (49).”
BackgroundShao, S., Fang, H., Dang, E., Xue, K., Zhang, J., Li, B., Qiao, H., Cao, T., Zhuang, Y., Shen, S., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00746 · Cited by 219
“In short, neutrophils and NETs can contribute to inflammation through several different mechanisms, through inflammasome activation (24), triggering of TLR7 and TLR9 by self-antigen complexes such as LL37DNA (25), promoting macrophage pyroptosis (26), or through processing and activation of IL-36 cytokines (27, 28).”
BackgroundMatsui, T., Connolly, J. E., Michnevitz, M., Chaussabel, D., Yu, C.-I., Glaser, C., Tindle, S., Pypaert, M., Freitas, H., Piqueras, B., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802008 · Cited by 219
“factor that mediates pDC activation (32).”
Amyloid-DNA Composites of Bacterial Biofilms Stimulate Autoimmunity
Gallo, P. M., Rapsinski, G. J., Wilson, R. P., Oppong, G. O., Sriram, U., Goulian, M., Buttaro, B., Caricchio, R., Gallucci, S., & Tükel, Ç. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.002 · Cited by 218
“A number of reports have suggested that DNA complexedwith a protein antigen can induce lupus-like disease (Desai et al., 1993; Lande et al., 2007).”
Immunopathogenesis of Psoriasis
Nickoloff, B. J., Qin, J.-Z., & Nestle, F. O. (2007) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-0039-2 · Cited by 217
Self-citationNijnik, A., Madera, L., Ma, S., Waldbrook, M., Elliott, M. R., Easton, D. M., Mayer, M. L., Mullaly, S. C., Kindrachuk, J., Jenssen, H., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901813 · Cited by 216
“synthetic cationic peptides with IL-1b, GM-CSF, and CpG oligonucleotides (38, 39, 46, 47).”
BackgroundCationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation
Liang, H., Peng, B., Dong, C., Liu, L., Mao, J., Wei, S., Wang, X., Xu, H., Shen, J., Mao, H.-Q., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06603-5 · Cited by 216
Keratinocyte: A trigger or an executor of psoriasis?
Ni, X., & Lai, Y. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0120-439r · Cited by 218
Recognition of nucleic acids by pattern‐recognition receptors and its relevance in autoimmunity
Kawasaki, T., Kawai, T., & Akira, S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01048.x · Cited by 217
“LL37 was implicated in mediating TLR9 and TLR7 responses to selfnucleic acids in psoriasis, a common chronic inflammatory disease in the skin (49, 115).”
BackgroundFukui, R., Saitoh, S.-I., Kanno, A., Onji, M., Shibata, T., Ito, A., Onji, M., Matsumoto, M., Akira, S., Yoshida, N., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.010 · Cited by 214
“…and 9, innate immune sensors for microbial RNA or DNA (Blasius and Beutler, 2010), have been implicated in autoimmune diseases such as psoriasis (Lande et al., 2007), arthritis (Asagiri et al., 2008), and systemic lupus erythematosus (SLE) (Christensen et al., 2006; Ehlers et al., 2006;…”
BackgroundSun, S., Sursal, T., Adibnia, Y., Zhao, C., Zheng, Y., Li, H., Otterbein, L. E., Hauser, C. J., & Itagaki, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059989 · Cited by 215
“To visualize localization of mtDNA in HPAEC, human mtDNA was labeled with Alexa 488 using the Ulysis Nucleic Acid Labeling Kit (Life technologies, Grand Island, NY) following the manufacturer’s protocol [12].”
MethodResolved Psoriasis Lesions Retain Expression of a Subset of Disease-Related Genes
Suárez-Fariñas, M., Fuentes-Duculan, J., Lowes, M. A., & Krueger, J. G. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.280 · Cited by 215
“In particular, production of LL37 and binding of self-RNA could trigger DC activation with accumulation of DC-LAMPþ DCs in the skin (Lande et al., 2007).”
Akashi-Takamura, S., & Miyake, K. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.07.001 · Cited by 213
Potential of immunomodulatory host defense peptides as novel anti-infectives
Easton, D. M., Nijnik, A., Mayer, M. L., & Hancock, R. E. W. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.07.004 · Cited by 215
“This activity might contribute to the pathology of psoriasis [70] Epithelial cells Keratinocytes LL-37 promotes keratinocyte migration and production of IL-8, inhibits keratinocyte apoptosis, modulates responses to TLR ligands, and might have wound healing activities in the skin.”
BackgroundGuiducci, C., Tripodo, C., Gong, M., Sangaletti, S., Colombo, M. P., Coffman, R. L., & Barrat, F. J. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101048 · Cited by 214
“LL37/CRAMP is a cationic antimicrobial peptide highly inducible in keratinocytes and has been shown to convert endogenous DNA and RNA into a potent TLR9 or TLR7 agonists by promoting aggregation and enhanced uptake by PDCs in vitro (Lande et al., 2007; Ganguly et al., 2009).”
BackgroundNeutrophil extracellular traps are associated with inflammation in chronic airway disease
Wright, T. K., Gibson, P. G., Simpson, J. L., McDonald, V. M., Wood, L. G., & Baines, K. J. (2016) · Respirology · doi:10.1111/resp.12730 · Cited by 213
Regulatory dendritic cells: there is more than just immune activation
Schmidt, S. V., Nino-Castro, A. C., & Schultze, J. L. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00274 · Cited by 212
“Unraveling differential and context-dependent signal integration by DCs during activation will also lead to the discovery of genes that could be targeted for immunomodulation.”
BackgroundSchmidt, N. W., Mishra, A., Lai, G. H., Davis, M., Sanders, L. K., Tran, D., Garcia, A., Tai, K. P., McCray, P. B., Ouellette, A. J., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja200079a · Cited by 213
Auvynet, C., & Rosenstein, Y. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07360.x · Cited by 212
Armstrong, A. W., Blauvelt, A., Callis Duffin, K., Huang, Y.-H., Savage, L. J., Guo, L., & Merola, J. F. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00630-5 · Cited by 200
Yarbrough, V. L., Winkle, S., & Herbst-Kralovetz, M. M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu065 · Cited by 209
“Endometrial HBD1 mRNA and protein expression is maximal during the mid-luteal phase, whereas HBD2, HBD3 and HBD4 peak at different times throughout the menstrual cycle and are not correlated with the implantation window (King et al., 2003b; Das et al., 2007).”
BackgroundInfluentialThe commensal skin microbiota triggers type I IFN–dependent innate repair responses in injured skin
Di Domizio, J., Belkhodja, C., Chenuet, P., Fries, A., Murray, T., Mondéjar, P. M., Demaria, O., Conrad, C., Homey, B., Werner, S., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0721-6 · Cited by 207
Self-citationImiquimod-Induced Psoriasis in Mice Depends on the IL-17 Signaling of Keratinocytes
Moos, S., Mohebiany, A. N., Waisman, A., & Kurschus, F. C. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.01.006 · Cited by 204
“, 1995), a defensin, which plays an important role in psoriasis (Lande et al., 2007).”
Background
Metadata
- Authors
- Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., Zal, T., Mellman, I., Schröder, J.-M., Liu, Y.-J., & Gilliet, M.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Genentech (US)
- Heinrich Heine University Düsseldorf (DE)
- King's College London (GB)
- Christian-Albrechts-Universität zu Kiel (DE)
- Corresponding author
- Gilliet, Michel
- ORCID
- Venue
- Nature
- Published
- 2007-09-16
- Volume
- 449
- Issue
- 7162
- Pages
- 564-569
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2084951281
- Cited by
- 1,910
- References
- 43
- Citations by year
- 2026: 54 · 2025: 61 · 2024: 87 · 2023: 81 · 2022: 94 · 2021: 93 · 2020: 89 · 2019: 97 · 2018: 92 · 2017: 118 · 2016: 105 · 2015: 81 · 2014: 113 · 2013: 120 · 2012: 181
- FWCI
- 38.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI074809)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- plasmacytoid dendritic cells, LL-37, antimicrobial peptides, self-DNA, TLR9, type I interferon, psoriasis, autoimmunity, innate immune tolerance, vaccine adjuvants, skin inflammation
- MeSH terms
- Autoantigens, Autoimmune Diseases, Dendritic Cells, DNA, Endocytosis, Humans, Psoriasis, Endosomes, Autoimmunity, Antimicrobial Cationic Peptides, Toll-Like Receptor 9, Cathelicidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.